BCL6 and B-cell non-Hodgkin lymphoma: TOX was also expressed in reactive GC B cells and in primary cutaneous B-cell lymphomas (BCL6+ primary cutaneous large B-cell lymphoma leg-type and secondary cutaneous DLBCL), indicating that this gene may play a role in B-cell lymphoma pathogenesis [15].